Abstracts:

Höhn Y. SOP-Verwaltung mit ViFlow. GV Solas 2012

Steitz J, Novak M, Kalf I, Höhn Y, Afify M, Eisert A, Englert U and Tolba R. Evaluation of efficiency and toxicity of a new platin-based chemotherapeutic agent for cancer therapy using the animal research platform ForSaTum. GV Solas 2012

Novak M, Berges N, Staudt M, Hehmann G, Melmer G, Tolba R and Steitz J. Establishment of a disseminated human Acute Myeloid Leukemia (AML) model in NOD/Scid gamma null mice for the evaluation of targeted cancer therapy. GV Solas 2012

Benjamin S. Gutrath, Martin F. Beckmann, Anne Buchkremer, Thomas Eckert, Jan Timper, Annika Leifert, Walter Richtering, Georg Schmitz, Ulrich Simon. Size Dependent, Multispectral Photoacoustic Response of Gold Nanoparticles. Abstract NanoBiomed 2012 (DECHEMA).

Schiffner M., Schmitz G. Plane wave pulse echo ultrasound diffraction tomography with a fixed linear transducer array. 31st International Symposium on Acoustical Imaging 2011.

Martin F. Beckmann, Martin P. Mienkina, Claus-Stefan Friedrich, Nils C. Gerhardt, Martin R. Hofmann, Georg Schmitz. Photoacoustic Coded Excitation using Periodically Perfect Sequences. IEEE International Ultrasonics Symposium 2011.

Kalenski, J., Tropartz, T., Teubner, A., Steitz, J., Tolba, R. Effect of Ectoine on Cryopreservation of sperm cells from C57BL/6 Mice. GV-Solas 2011.

Steitz J. Development of a specialized animal research platform for the longitudinal analysis of novel treatment concepts for canacer therapy. GV-Solas 2011.

A. Roesmann, M. Afify, R. Osieka, A. Eisert, R. Tolba. Amelioration of acute liver toxicity of L-Asparaginase by using L-Carnitine. GV-Solas 2011.

Poster:

Novak M, Berges N, Staudt M,  Hehmann G,  Melmer G, Tolba R and Steitz J. Establishment of a disseminated human Acute Myeloid Leukemia (AML) model in NOD/Scid gamma null mice for the evaluation of targeted cancer therapy. GV Solas 2012

Weißler B, Düppenbecker PM, Gebhardt P, Salomon A, Goldschmidt B, Marsden PK, Kießling F, Schulz V. World?s first preclinical 3T PET/MR insert with fully digital silicon photomultiplier technology. WMIC 2012.

Rawashdeh WA. Polymeric nanoparticles as OCT contrast agents. WMIC 2012

Amoury M, Nachreiner T, Barth S. Single-chain based fusion proteins for the diagnosis and treatment of triple negative breast cancer. Biomedica 2012

Kessler C, Pardo A, Kolberg K, Fischer R, Barth S. Selection and characterization of specific antibodies for diagnosis and immunotherapy of prostate cancer. Biomedica 2012

Hein L, Amoury M, Fischer R, Barth S, Nachreiner T. Generation of scFvC54-based immunotoxins and specific targeting of EpCam positive breast cancer cells. Biomedica 2012

Steitz J. Development of a specialized animal research platform for the longitudinal analysis of novel treatment concepts for cancer therapy. CIMT Mainz 2011.

A. Roesmann, M. Afify, R. Osieka, A. Eisert, R. Tolba. Amelioration of acute liver toxicity of L-Asparaginase by using L-Carnitine. ESSR 2011.

Vorträge:

Steitz J, Novak M, Kalf I, Höhn Y, Afify M, Eisert A, Englert U and Tolba R. Evaluation of efficiency and toxicity of a new platin-based chemotherapeutic agent for cancer therapy using the animal research platform ForSaTum. GV Solas 2012

Höhn Y. SOP-Verwaltung mit ViFlow. GV Solas und IGTP 2012

Rawashdeh WA. Combined OCT/NIRF-OT for non-invasive tumor stage. Pathology Weekend 2011 UK Aachen 

Koczera P. USPIO-containing PBCA Microbubbles for Mediating and Monitoring Blood-Brain Barrier Permeation. WMIC 2012

Koczera P. USPIO-containing PBCA Microbubbles for Mediating and Monitoring Blood-Brain Barrier Permeation. MoBi 2011

Steitz J. Development of a specialized animal research platform for the longitudinal analysis of novel treatment concepts for cancer therapy. ICLAS 2011.

Franken T. Herausforderung des Projektmanagements in Forschungsnetzwerken, Bsp. ForSaTum. GPM 2011.

Wissenschaftliche Publikation:

Rawashdeh WA. Polymeric nanoparticles as OCT contrast agents. Submitted to Journal of Nanoparticle Research (under revision). (2012)

Kiessling F, Fokong S, Koczera P, Lederle W, Lammers T, Ultrasound Microbubbles for Molecular Diagnosis, Therapy, and Theranostics, J Nucl Med. 2012 Mar;53(3):345-8.

Koczera P, Wu Z, Fokong S, Theek B, Appold L, Jorge S, Möckel D, Liu Z, Curaj A, Storm G, van Zandvoort M, Kiessling F, Lammers T, Fluorescently labeled microbubbles for facilitating translational molecular ultrasound studies, Drug Deliv. and Transl. Res. (2012) 2:56?64.

Lederle W, Palmowski M, Kiessling F. Imaging in the age of molecular medicine: Monitoring of anti-angiogenic treatments. Current Pharm Biotech (in press).

Lammers T, Kiessling F, Hennink W, Storm G. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. J Control Release (in press) .

Kunjachan S, Jayapaul J, Mertens M, Storm G, Kiessling F, Lammers T. Theranostic systems and strategies for monitoring nanomedicine-mediated drug targeting. Curr Pharm Biotech (in press) .

Kunjachan S, Blauz A, Moeckel D, Theek B, Kiessling F, Etrych T, Ulbrich K, van Bloois L, Storm G, Bartosz G, Rychlik B, Lammers T. Overcoming cellular multidrug resistance using classical nanomedicine formulations. Eur J Pharm Sci (in press).

Koczera P, Wu Z, Fokong S, Theek B, Appold L, Jorge S, Moeckel D, Liu Z, Curaj A, Storm G, van Zandvoort M, Kiessling F, Lammers T. Fluorescently labeled microbubbles for facilitating translational molecular ultrasound studies. Drug Deliv Transl Res (in press).

Benjamin S. Gutrath, Martin F. Beckmann, Anne Buchkremer, Thomas Eckert, Jan Timper, Annika Leifert, Walter Richtering, Georg Schmitz, Ulrich Simon. Size dependent, multispectral photoacoustic response of solid and hollow gold nanoparticles. Nanomaterials, in press 2012.

Abou-Elkacem L, Gremse F, Barth S, Hoffman RM, Kiessling F, Lederle W. Comparison of μCT, MRI and optical reflectance imaging for assessing the growth of GFP/RFP-expressing tumors. Anticancer Res. 31: 2907-2913 (2011).

Fokong S, Siepmann M, Liu Z, Schmitz G, Kiessling F, Gätjens J. Advanced characterization and refinement of poly N-butyl cyanoacrylate microbubbles for ultrasound imaging. Ultrasound Med Biol. 37: 1622-1634 (2011).

Lederle W, Arns S, Rix A, Gremse F, Doleschel D, Schmaljohann J, Mottaghy FM, Kiessling F, Palmowski M. Failure of annexin-based apoptosis imaging in the assessment of antiangiogenic therapy effects. EJNMMI Res. 1: 26 (2011).

Lammers T, Aime S, Hennink W, Storm G, Kiessling F. Theranostic Nanomedicine. Acc Chem Res 44: 1029-1038.

Lammers T, Kiessling F, Hennink W, Storm G. Nanotheranostics and image-guided drug delivery: current concepts and future directions. Mol Pharmaceut 7: 1899-1912 (2010).

Lammers T, Storm G, Kiessling F. Nanomedicine formulations for combination therapies. Nano Reviews 1: 5705 (2010).

 

 

Forschungssatellit für eine beschleunigte Umsetzung neuer Tumorbehandlungskonzepte - Handout.